Antibodies Against Membrane Protein Targets banner

As the pharmaceutical and biotech industries increasingly shift attention to biologics, much more attention is being paid to the prospect of developing biotherapeutics against membrane-bound targets. For the large GPCR and ion channel target classes, biologics offer improved selectivity, an alternative for targets with known function that have not been amenable to small molecule drugs and the potential for using antibodies for the targeted delivery of therapeutics. The PEGS Europe Membrane Protein conference provides a forum in which discovery biologists and protein engineers can come together to discuss next-generation strategies and technologies that will allow biologic drugs for these target families to advance into the clinic and beyond.

Recommended Short Course*
Monday, 13 November, 14:00 – 17:00
SC5: Best Practices for Targeting GPCRs, Ion Channels, and Transporters with Monoclonal Antibodies
*Separate registration required. See short courses page for details. All short courses take place in-person only.

For more details on the conference, please contact:

Kent Simmons
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 207-329-2964


For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340